How to Educate Clients on CBD Oil Use

Veterinary Practice News, September 2021
By Angie Krause, DVM, CVA, CCRT

They were getting such great results with their personal anxiety, body aches and pain, and other conditions, and wanted to extend those same results to their pets. 

At the time, I know very little about marijuana or even cannabidiol (CBD). Soon, I noticed a trend with many of my patients being dosed with marijuana, either intentionally or accidentally, It was then when I began to educate myself about the cannabis plant in order to have informed discussions with clients about the pros and cons of its use in dogs and cats. 

Read the full article here.


DermaZoo Launches ChronoZoo at VMX, WVC 2020

January 2020

Hemp-Zoo Highly Concentrated
Hemp Extract for Dogs and Cats

– Full Spectrum
– No Flavorant Added
– All-natural

1500 mg (50 mg/ml)

Read the article:
CBD 101: Wholesale to the vet market by Lindsay McAuliffe, DVM
Resident in Dermatology, University of Missouri


DermaZooTM Launches NEW TrisDentTM Treats

April 24, 2018 – DermaZoo is pleased to announce the release of its new Intellectual Property Protected dental treat for dogs as part of its TrisDentTM Dental Products line. The new product, TrisDentTM Treats, are the first to utilize the innovative combination of Tris-EDTA (Tromethamine and Edta) for which the TrisDent line is known. This nutritious and enjoyable chew supports the health of teeth and gums and improves breath.

The unique combined dental formulation of TrisDentTM Treats offers irresistible taste, antimicrobial action, Chelation of minerals ( which cause dental plaque to mineralize into calculus), binding to the biofilm and dual cleaning action. The abrasive effect of the treat also loosens plaque as the pet chews.  TrisDent Treats are all-natural and xylitol free, containing no beef or beef by-products, and are made in the USA.

TrisDentTM Dental Products are also available as a Water Additive, Oral Rinse, Wipe and Gel.

Download the TrisDent Treats product bulletin here.

Treatment and Prevention of Otitis Externa in Dogs

The following is a summary of Dr. Conchita Hernan-Perez Gonzalez’s article: Treatment and Prevention of 95% of Cases of Otitis Externa in Dogs Caused by Malassezia Spp., with a Boric Acid, Glycolic Acid and Ceramides Solution which was published in May of 2017.

Otitis Externa is an acute infection of the ear canal caused by organisms such as Staphylococcus spp, Pseudomonas spp, Streptococcus spp, Escherichia coli spp, Klebsiella spp, Bacteroides spp, Pasteurella spp and Malassezia spp.

The most common type of external ear infection found in many warm-blooded vertebrates is Malassezia pachydermatis, a lipophilic yeast found in the stratum corneum. An effective treatment for Malassezia is the GlycoZoo Otic, an aqueous solution for dogs, cats, and horses containing Boric acid, Glycolic Acid and Ceramides. It has antimicrobial, ceruminolytic, keratolytic, lipolytic, drying, non-irritating and regenerating properties that work well against Malassezia.

The Boric Acid has a drying action and can inhibit fungal metabolism in Malassezia.  Glycolic Acid, a very small molecular Alpha Hydroxy Acid, easily penetrates the deep layers of the skin. It is exfoliating, keratolytic and lipolytic. Ceramides are waxy lipid molecules found in the stratum corneum of the skin that join the cells together. Ceramides promote regeneration and repair of the skin as well as restoring the skins hydration.

In a recent study performed by Dr. Conchita Hernan Perez Gonzalez, 40 dogs diagnosed with Malassezia were treated with GlycoZoo Otic. Over a period of 10 months, 95% of the dogs showed a decrease in Malassezia spp.  In puppies, the treatment was rapid and effective taking only approximately 15 days. However, in the more chronic cases of Malassezia seen, the treatment took on average 45 days.

Many commercial otic products on the market contain topical antibiotics and steroids which can predispose dogs and cats to otomycosis. These antibiotic treatments used within the ear canal destroy the microbiome and pathogenic microorganisms within the ear. In fact, a very large percentage of dogs diagnosed with otitis externa are atopic and actually have fewer species in their microbiome. Therefore, it is important to administer a treatment such as GlycoZoo Otic that does not alter the microbiome of the ear while still having an antimicrobial, ceruminolytic, keratolytic, lipolytic, drying, non-irritating and regenerating effect against Malassezia.

Zeke Melman, Western University of Health Sciences, College of Veterinary Medicine

Here is the full article translated from Spanish:

(May 25, 2017) Treatment and Prevention of 95% of Cases of Otitis Externa in Dogs Caused by Malassezia Spp., with a Boric Acid, Glycolic Acid and Ceramides Solution (GlycoZoo® Otic ABELIA)

GlycoZoo® Otic trades as ABELIA in Spain

Dr. Conchita Hernán-Pérez González
Centauro Veterinarios

The aim of this study was to test the efficacy of GlycoZoo® [Otic] ABELIA in the treatment and prevention of otitis caused by Malassezia spp. in the dog.

Otitis externa, an inflammation of the external ear canal and, sometimes, the pinna, is a common pathology in small animals. It occurs in 4.6% of the population (11). 40-50% are atopic dogs (8). Within this group, in 43%, the owners describe otitis as the first observed clinical sign (9).

Otitis externa has a multifactorial etiology and treatment may be difficult in some cases. The most commonly isolated organisms in dogs with otitis externa are Staphylococcus spp, Pseudomonas spp, Streptococcus spp, Proteus spp, Escherichia coli spp, Klebsiella spp, Bacteroides spp, Pasteurella spp and Malassezia spp.

Otomycosis accounts for 26.7% of diagnosed cases of otitis (11). The most common microorganism in dog otomycosis is Malassezia pachydermatis. Malassezia pachydermatis is a lipophilic yeast that is part of the normal cutaneous microflora of many warm-blooded vertebrates. Alterations in the microclimate of the cutaneous surface or in the host defenses help the proliferation of Malassezia (5). Since this microorganism is located in the stratum corneum, topical therapy may be sufficient to resolve clinical signs of infection (5).

GlycoZoo® [Otic] ABELIA is an aqueous otic solution for dogs, cats and horses containing Boric acid, Glycolic acid and Ceramides. It has antimicrobial, ceruminolytic, keratolytic, lipolytic, drying, non-irritating and regenerating properties.

Boric acid has drying action and is effective against Malassezia infections (6). The mechanism of action of boric acid is not well known. It has been proposed that boric acid can inhibit the ability of fungi to carry out their metabolism.

Glycolic acid is a very small molecular chain alpha hydroxy acid (AHA), allowing it to easily penetrate the deeper layers of the skin. It is exfoliating, keratolytic and lipolytic. Its exfoliating effect favors the detachment of the most superficial cells of the epidermis, favoring normal keratinization and hydration. In addition, by eliminating dead cells, it allows a greater contact of the active ingredients with the epithelium (12).

Ceramides are a complex of sphingolipids found in the stratum corneum of the skin. Their function is to join the cells together. Their presence contributes to maintain the barrier effect, to repel aggressions and to avoid that microorganisms and allergens penetrate the skin. They promote regeneration and repair of the skin and help restore its natural hydration.

This is an open, uncontrolled field study in which all patients received the same treatment. The study included 40 dogs diagnosed with Malassezia spp. By cytology. The retrospective study was carried out over 10 months. The treatment that was applied was an otic solution with antimicrobial, ceruminolytic, keratolytic, lipolytic, drying and regenerative properties, based on boric acid, glycolic acid and ceramides. In the initial phase of treatment, the owners applied GlycoZoo® [Otic] ABELIA every 12-48 hours depending on the physical examination or the anatomical characteristics and morphology of the patient’s ear. In the maintenance phase, the product was applied every 7 days. Data on breed, sex, age, date of otitis appearance, unilateral versus bilateral, associated pathologies, physical examination, cytological findings, previous treatments and clinical response are attached in Table I. All dogs were reviewed weekly during the initial phase of treatment and every 2-4 weeks in the maintenance phase. The criterion to consider a patient cured and to move to the maintenance phase was based on the resolution of clinical signs: pruritus, pain, ulceration, erythema, characteristic odor to Malassezia, brown ceruminous remains, hyperkeratosis thickening of the folds of the pinna, stenosis-duct hyperplasia and subsequent cytology confirming the decrease or disappearance of the population of Malassezia (1), considering a count of less than 5 Malassezia spp. per field of 40x. (10).

In 95% of the dogs the clinical signs were resolved favorably. Cytology showed a decrease or elimination of Malassezia spp. The response to treatment was faster in young animals in which Malassezia spp overgrowth had been diagnosed for the first time; in these cases the average duration of the treatment phase was 15 days. In the more chronic cases, the mean duration of the initial phase of treatment, to reach clinical and cytological resolution, was 45 days. The two refractory cases were very chronic cases with ductal stenosis and hyperplasia; even so, in one of them there was a partial improvement. The product was tolerated perfectly in all cases, provided immediate comfort from the first application and was not irritating.

In the past, when I was facing otitis externa, after cytology, I used to start a cleansing treatment. In most cases, this was not enough to improve the clinical signs and control the overgrowth of Malassezia and bacteria, so I had to use topical “cocktail” products combining antibiotics, antifungals, and steroids (6). The existing commercial product available in our market do not combine all the GlycoZoo® [Otic] ABELIA properties: if they have great antimicrobial power, they are irritating; and if they carry sphingolipids or ceramides they are not good cleansers and antimicrobials. GlycoZoo® [Otic] ABELIA prevents and treats otitis externa caused by Malassezia without adding antibiotics, antifungals or steroids.

In human medicine, the use of topical antibiotics and steroids has been reported among the predisposing causes of otomycosis (7). Much remains to be learned about the antimicrobial composition and susceptibility of the microbiome of the dog’s skin (2). It is not clear that the alteration of the microbiome is the cause or the consequence, but the restoration and stabilization of the microbiome, are key objectives to treat or prevent the disease (2). We must prevent the manipulation of the microbiome of the ear and the skin of the dog avoiding the use of antibiotics and antifungals. The conventional antibiotic treatments we use are destroying most of that microbiome, and destroy both beneficial microorganisms and pathogens. The objective would be not to eliminate them in such an indiscriminate way (2). To understand the role of the microbiome, in health and in the disease, it is really important to know the complex interactions between its different bacterial components, between bacteria and other microorganisms, and between the microbiome itself and the immune system (3).

Traditionally, to treat infections in the skin of animals, we focused on using antibiotics to treat the pathogen found in the culture (4). But in practice, the elimination of this is unlikely, since clinical cure and cure are not the same. In addition, most of the microorganisms treated are the same as those found in healthy skin (5).

Since we are aware of the spread of multi-drug resistant organisms, such as methicillin-resistant Staphylococcus, conventional antibiotic therapies are no longer considered effective or safe.

A high percentage of dogs with otitis externa are atopic (8,9). These have a fewer species in their microbiome and develop dysbiosis of the same when they face the allergens to which they are sensitized (3). That is why we should look for treatments that minimally alter the microbiome.

GlycoZoo® [Otic] ABELIA is a promising alternative to conventional treatments for otitis due to its effectiveness against Malassezia because it does not alter the dog’s ear microbiome and because of the low possibility of inducing fungal resistance.

Full References Listed Here.

Original Paper in Spanish Here.


GlycOat Bottles(May 15, 2015) DermaZoo® Pharma LLC is proud to announce the release of GlycOat Shampoo and GlycOat Conditioning Spray, two soothing and nourishing general cleansing products for use on normal, dry, oily, scaly skin and/or coat. The oatmeal extract in these products is anti-pruritic and soothing, while the glycolic acid is keratolytic and nourishing, exfoliating dead skin cells and allowing the oatmeal extract to get to the source and act as an anti-pruritic/soothing agent. GlycOat Shampoo also includes Ceramides to aid in moisturizing, repairing and restoring dry, damaged skin. GlycOat Spray comes in an easy to use leave-on, dry-on formula.

“Even animals without skin problems can suffer from dry, itchy skin and can benefit from the use of a soothing and hydrating topical oatmeal product, such as GlycOat Shampoo and Conditioner. This is usually caused by dry environmental conditions or central heating which lead to increased transepidermal water loss,” comments Dr. Jessica Melman, Director of Veterinary and Technical services at DermaZoo.

GlycOat Shampoo and Conditioning Spray for dogs, cats and horses is available in 8 oz bottles. GlycOat Shampoo and Spray may be purchased soon through Victor Medical, Henry Schein, MWI and Midwest.